KBLB Kraig Biocraft Laboratories Inc.

24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlights Kraig Biocraft Laboratories Science Powering Recombinant Spider Silk Production

24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlights Kraig Biocraft Laboratories Science Powering Recombinant Spider Silk Production

March issue of National Geographic explores how engineered silkworms are spinning one of nature’s most powerful materials at scale

DENVER, Feb. 24, 2026 (GLOBE NEWSWIRE) -- , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the undisputed global leader in the development and commercialization of spider silk, is currently the National Geographic magazine March issue cover feature. The March issue highlights a major science breakthrough in an article titled “Unlocking Nature’s Miracle,” which examines the decades-long global effort to manufacture spider silk, a material widely regarded as one of the strongest and toughest fibers found in nature.



In a section headlined “Somewhere in Michigan,” the article takes readers inside a production environment where genetically engineered silkworms are spinning fibers designed to replicate the molecular structure of natural spider silk. The feature presents this work as part of the broader scientific race to translate spider silk from laboratory curiosity into scalable biomaterial.

The article explains that spider silk derives its extraordinary performance from specialized proteins known as spidroins. Inside a spider’s gland, these proteins transition from liquid form into aligned crystalline and amorphous regions, producing a fiber that combines tensile strength, elasticity, and toughness in ways rarely matched by synthetic materials.

Because spiders cannot be farmed at industrial scale, researchers have pursued alternative biological hosts. The feature describes how Kraig Biocraft Laboratories (OTCQB: KBLB) has developed genetically engineered silkworm strains capable of producing recombinant spider silk proteins. By leveraging the silkworm’s natural spinning system, refined over thousands of years of domestication, the approach seeks to combine modern genetic engineering with existing agricultural silk infrastructure.

The article places this Michigan-based production alongside other international efforts, including fermentation-driven systems, presenting a balanced overview of the science.

The emphasis remains on:

  • Molecular engineering of silk proteins
  • Host-organism scalability
  • Fiber formation mechanics
  • Performance testing
  • Potential textile and biomedical applications



The imagery and demonstrations featured in the article underscore a key theme: recombinant spider silk is no longer theoretical. It is being produced, tested, and evaluated within real-world environments.

For readers interested in advanced materials, synthetic biology, or next-generation sustainable fibers, the March issue provides one of the most comprehensive mainstream overviews of the field to date.

24/7 Market News encourages readers and industry observers to obtain a copy of this month’s National Geographic to review the full feature and explore the scientific context in depth. Interested persons can order a copy of the magazine from National Geographic at .

You can purchase a digital copy of the article directly from National Geographic at

** Photography by Mark Thiessen, NGM Staff, Image Copyright: National Geographic Magazine

As recombinant biomaterials continue to move from laboratory research toward commercial production, independent coverage from globally recognized science publications reflects growing mainstream attention to the field.

Please to read the full Kraig Labs analyst report on 247marketnews.com.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is a biotechnology company focused on the development and commercialization of spider silk-based fiber technologies. Through its proprietary silkworm-based genetic engineering platform, Kraig Labs produces high-performance, cost-effective, and scalable spider silk materials for use in defense, performance apparel, technical textiles, and medical applications.

For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit

About 24/7 Market News

In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is a third-party media provider that owns KBLB shares, which are on deposit and may be sold at the editor’s discretion, and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.

For further information, please visit or

CONTACT:

24/7 Market News

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.

A photo accompanying this announcement is available at



EN
24/02/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

From Milestone to Momentum: Kraig Biocraft Leadership Travels to South...

From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle ANN ARBOR, Mich., April 13, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that senior management is traveling to South East Asia this week to build on the momentum of its recently announced record-setting production of 1.3 metric tons of recombinant spider silk cocoons in a single month. The v...

 PRESS RELEASE

From Genetic Puzzle to Industrial Platform

From Genetic Puzzle to Industrial Platform Kraig’s Breakthrough Moment Could Redefining Advanced Materials DENVER, April 08, 2026 (GLOBE NEWSWIRE) -- () - For years, the promise of spider silk has lived at the intersection of science fiction and cutting-edge biotechnology, an advanced material has long been celebrated for its extraordinary combination of strength, elasticity, toughness, biocompatible, biodegradable, and low weight, properties that outperform steel on a strength-to-weight basis and more versatile than high-performance synthetics such as Kevlar. Spider silk’s amazing pot...

 PRESS RELEASE

Kraig Biocraft Laboratories Shatters Production Record, Delivering Ove...

Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High Record-breaking output validates aggressive scale-up strategy as Company accelerates toward 10 metric tons per month ANN ARBOR, Mich., April 06, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that it has produced more than 1.3 metric tons of recombinant spider silk cocoons in a single month. This is...

 PRESS RELEASE

From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets A...

From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk DENVER, April 02, 2026 (GLOBE NEWSWIRE) -- () -- Kraig Biocraft Laboratories (OTCQB: KBLB) is advancing a transgenic silkworm platform designed to produce recombinant spider silk at commercial scale, positioning the company at the intersection of genetic engineering, materials science, and textile manufacturing. Spider silk has long been studied for its combination of strength, elasticity, and low weight. The challenge has been producing it economically at scale. Kraig’s approac...

 PRESS RELEASE

Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Productio...

Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan ANN ARBOR, Mich., March 30, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced the successful deployment of more than 700,000 BAM-1 Alpha production hybrids of its previously reported 1,000,000 egg inventory. These silkworms are now in active production. This achievement underscores the Company's continued execution of its previou...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch